BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9331690)

  • 1. Group A streptococci. Erythromycin resistance and penicillin tolerance.
    Savoia D; Millesimo M; Dotti G; Milano F
    Adv Exp Med Biol; 1997; 418():447-9. PubMed ID: 9331690
    [No Abstract]   [Full Text] [Related]  

  • 2. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study.
    Cocuzza CE; Mattina R; Mazzariol A; Orefici G; Rescaldani R; Primavera A; Bramati S; Masera G; Parizzi F; Cornaglia G; Fontana R
    Microb Drug Resist; 1997; 3(4):371-8. PubMed ID: 9442490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillin tolerance in group A streptococci.
    Dündar G; Babacan KF
    Adv Exp Med Biol; 1997; 418():457-9. PubMed ID: 9331693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Streptococcal pharyngitis].
    Romero J; Betriu C
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):611-27. PubMed ID: 8808478
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of penicillin tolerance in group A streptococci.
    Stjernquist-Desatnik A; Orrling A; Schalén C; Kamme C
    Adv Exp Med Biol; 1997; 418():439-41. PubMed ID: 9331688
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.
    Avanzini C; Bosio K; Volpe G; Dotti G; Savoia D
    Microb Drug Resist; 2000; 6(4):289-95. PubMed ID: 11272257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
    Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
    J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci.
    Jasir A; Schalén C
    Adv Exp Med Biol; 1997; 418():443-5. PubMed ID: 9331689
    [No Abstract]   [Full Text] [Related]  

  • 10. [The frequency of group A beta-hemolytic Streptococcus in acute tonsillopharyngitis and therapy with cefadroxil, clavulanic acid-amoxicillin combination and erythromycin in patients unresponsive to procaine penicillin therapy].
    Tuncer AM; Kunak B; Kirsaç N; Yeğinaltay T; Kotiloğlu G; Can R; Güngör A; Nalça M
    Mikrobiyol Bul; 1987 Jul; 21(3):172-7. PubMed ID: 3332700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe Group A Streptococcal infections and community acquired infections].
    Schalén C; Hoffmann S
    Lakartidningen; 2015 Sep; 112():. PubMed ID: 26393978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharyngotonsillitis caused by Streptococcus pyogenes: clinical and epidemiological aspects and resistance phenotypes towards macrolides].
    Crotti D; D'Annibale ML; Ubaldi M; Fonzo G; Medori MC
    Infez Med; 2002 Dec; 10(4):213-9. PubMed ID: 12754427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis.
    Milatovic D
    Pediatr Infect Dis J; 1991 Oct; 10(10 Suppl):S61-3. PubMed ID: 1945599
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for detection of penicillin tolerance in Streptococcus pyogenes by MIC-MBC method.
    Van Asselt GJ; Van Boven CP
    Adv Exp Med Biol; 1997; 418():451-2. PubMed ID: 9331691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin-resistant group A streptococci.
    Linder JA; Stafford RS
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in epidemiologic characteristics and antimicrobial resistance of
    Ubukata K; Wajima T; Morozumi M; Sakuma M; Tajima T; Matsubara K; Itahashi K; Iwata S
    J Med Microbiol; 2020 Mar; 69(3):443-450. PubMed ID: 32011228
    [No Abstract]   [Full Text] [Related]  

  • 18. [Consensus statement on antimicrobial treatment of pharyngo-tonsillitis].
    ; ; ; ; ;
    Rev Esp Quimioter; 2003 Mar; 16(1):74-88. PubMed ID: 12756993
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between differences in 16-, 14-, and 15-membered ring macrolides and Streptococcus pyogenes resistance.
    Braga PC
    Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):146-8. PubMed ID: 11939399
    [No Abstract]   [Full Text] [Related]  

  • 20. Opacity factor inhibition test for typing group A beta-haemolytic streptococcus strains and antibiotic susceptibility.
    Yang YH; Shen XZ; Totolian A; Beliakova I
    Adv Exp Med Biol; 1997; 418():45-7. PubMed ID: 9331595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.